White paper: Principles for Codevelopment of an In Vitro Companion Diagnostic Device with a Therapeutic Product

FDA draft guidance on the Principles for Codevelopment of an In Vitro Companion Diagnostic Device with a Therapeutic Product, published on July 14, 2016, can be viewed as a testament to the Agency’s commitment to incorporate scientific advances into its regulatory framework. In the 90 days this “how-to guide” was open for comment some 15 companies and associations responded, including Diaceutics.
Existing Users Log In